Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies

Cited in blog · Diabetes, Obesity and Metabolism. · 2024

Neeland IJ, et al. (2024). Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes, Obesity and Metabolism.